Rubicon Research is an IP led, specialty pharmaceutical company focused on our mission to provide innovative yet affordable patient-centered products and solutions so as to address unmet needs around the world. We leverage our proprietary technologies and specialized formulation development skills to provide solutions to complex delivery challenges; enabling better patient outcomes.
Our portfolio spans multiple dosage forms, including oral solids, oral liquids, nasal, ophthalmic, injectable, topical, drug device combinations and fixed-dose combinations. We hold more than 50 issued patents in drug delivery technologies, and have launched over 64 SKUs, with over 1.3+ billion extended units sold in the US in 2020. In the pipeline are 10+ approvals and launches (across oral solids and ophthalmic formulations) slated for 2021. Additionally, there are more than 130 products in development and 22 filed products under review with the US FDA.
- Departments: Production / QA / QC / ARD / Regulatory Affairs / Formulation Development
- Qualification: M.Sc / B.Pharm / M.Pharm
- Location: Ambernath / Thane / Satara
Date: 26th & 27th May’ 2022
Time: 10:00 am to 01:00 pm
Venue: MedOne House, Plot. No: B-75, Road No – 33, Wagle Estate, Thane – (W) – 400604, Maharashtra